In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®

Conditions:   Melanoma;   Head and Neck Cancer;   Sarcoma;   Non-Melanoma Skin Cancers
Intervention:   Biological: Hiltonol
Sponsors:   Oncovir, Inc.;   National Institutes of Health (NIH);   Icahn School of Medicine at Mount Sinai;   Bay Hematology Oncology;   Medical University of South Carolina;   Emory University;   University of Pittsburgh;   National Cancer Institute (NCI)
Recruiting - verified March 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1SjmDra
via IFTTT